 Patients present to the ER with high levels of pain and are often undertreated.  The high cost, approximately $150, to administer IV opioids may contribute to this "oligoanalgesia."  In the current healthcare reimbursement environment, it would be optimal to have access to a rapid-onset analgesic for treatment of moderate-to-severe pain that does not require IV administration so as to reduce the overall cost of treatment.
The lack of appropriate pain management in the emergency room setting has been a longstanding issue and led to the term ED "oligoanalgesia" in 1989. 3 There are many factors, whether justified or not, that lead to this phenomenon including fear that patients are drug-seeking and concern over masking the patient's underlying condition, thereby making the diagnosis more difficult. However, another important and relevant factor that may influence the undertreatment of patients in pain is the time and cost to set-up and administer intravenous (IV) opioids in the ED setting.
While IV opioids have been utilized for decades to rapidly treat moderate-to-severe pain in the ED, very little data exists regarding the costs of administering a typical dose of IV opioid in this setting. This study analyzed the current costs to administer a single dose of commonly utilized IV opioids in EDs throughout the US.
Descriptive analyses using the Premier database (2013) (2014) of > 600 US hospital EDs were conducted on the cost of starting an IV and delivering an initial dose of an IV opioid in EDs. Average costs of each component were aggregated for total costs. Direct acquisition and indirect cost (labor, pharmacy, etc.) were included.
Cost included in the analysis:  Direct acquisition cost  Indirect cost (labor, pharmacy, etc.)  Costs related to initiating an IV infusion, IV equipment (catheter, tubing, saline, pump, etc) and the dose of a standard initial IV opioid were included. Lidocaine 2% for local anesthesia prior to catheter insertion was also included. Database cost entries were analyzed across all hospital EDs and mean, median and range are reported.
 Over 24 months, 7,327,299 patients received IV opioids in 614 EDs in the US (approximately one-tenth of EDs in the US).  Of these patients, 3,055,611 (58%) were not admitted to the hospital and were discharged to home from the ED.  The average age of ED patients receiving IV opioids was 51 years old; see 
OBJECTIVES
Evaluation of the cost of delivering IV opioids in the emergency department (ED) for the treatment of acute pain has been limited to date. This study estimates the cost of delivering an initial dose of an IV opioid to ED patients.
METHODS
Descriptive analyses using the Premier database (2013-2014) of > 600 US hospital EDs were conducted on the cost of starting an IV and delivering an initial dose of an IV opioid in EDs. Average costs of each component were aggregated for total costs. Direct acquisition and indirect cost (labor, pharmacy, etc.) were included.
RESULTS
Over 24 months, 7,327,299 patients received IV opioids in 614 EDs in the US (approximately one-tenth of EDs in the US). Of these patients, 58% were not admitted to the hospital. Morphine (56%), hydromorphone (45%) and fentanyl (25%) were the most frequently administered IV opioids. Average 
CONCLUSIONS
The cost of setting up an IV line to administer an opioid is substantial. Since the majority of patients receiving IV opioids are discharged from the ED, the ultimate use for this IV line is limited. The development of a rapid-acting, non-invasive analgesic for ED use could be advantageous from both a cost and patient-benefit standpoint. 
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Patient demographic data, payor data, as well as hospital descriptive data (location, size, type of hospital; see Table 1) were also collected. A comparison between patients who were ultimately admitted as inpatients versus the patients who were discharged from the ED was also performed.
Table 2. Demographics of Patients Receiving IV Opioids in the ED

Methods
Methods (cont.)
Relative to the overall demographic of patients receiving IV opioids in the ED, patients that were admitted to the hospital tended to be older (average age 59 vs 51). Slightly more male patients were admitted (46%) relative to those who received IV opioids (41%), however the majority still remained female. Consistent with the older age of admitted patients, relatively more Medicare patients were admitted (50%) relative to the percent of Medicare patients receiving IV opioids (35%).
Most frequently administered IV opioid drugs in the EDs are shown in Table 3 below.
In Table 4 , the cost of each individual item was listed along with the mean, median and cost range. Standard initial dosages of the three most commonly administered IV opioids in the ED (morphine, hydromorphone and fentanyl) were included. The costs above are largely due to the nursing time and equipment costs to set-up and maintain an IV infusion in order to administer IV opioids as needed. The mean cost of each standard dose of IV opioid was not substantial ($6 -$7). Over a typical ED visit treatment time of 90 minutes, 4 typical dosing of IV morphine would be approximately 0.15 mg/kg (or the equivalent of approximately 2 doses of the above standard IV opioids in a 70-kg patient). 5 Therefore, adding the second dose of IV opioid, the total cost of IV opioid treatment in the ED would average $149 -$152. 
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